UICMEW | Evaluation Questionnaire

UICMEW | Evaluation
We greatly value your opinion. Please complete this evaluation and submit it to the registration desk at the conclusion of this activity. Your
responses will be used in future planning of activities and materials.
I am a:

Upon completion of this activity, participants will be able to:

Participants will be able to evaluate the efficacy and safety of using PARP inhibitors in managing HRR- mutated metastatic prostate cancer, including potential side effects and monitoring parameters.
Participants will be able to review the latest guidelines and recommendations for peri-operative therapy in localized rectal cancer.
Participants will identify the role and significance of biomarkers in early and advanced-stage non-small cell lung cancer.

Upon completion of this activity, participants will be able to:

Discuss current and future roles of newly approved targeted therapies in all breast cancer subtypes.
Understand the side effects of practice-changing novel therapies and their integration into community practice.
Discuss emerging strategies for patients with platinum-resistant ovarian cancer.

Upon completion of this activity, participants will be able to:

Discuss the optimal strategies for the use of CAR T Cell and bispecific T-cell engagers in Diffuse Large B Cell Lymphoma.
Explain how to optimize treatment selection in Multiple Myeloma, including the use of bispecific T- Cell engagers.
Identify novel treatment approaches in Acute Lymphoblastic and Acute Myeloid Leukemia.

Please indicate the extent of your agreement with the following statements:

The faculty for this activity were effective.
The education resources and/or handouts provided to me at the educational activity are useful to my practice.
Overall, was this fair, balanced and free from commercial bias?
Of the patients you will see in the next week, about how many will benefit from the information you learned today?
Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
Which ONE delivery method do you find the most effective for CME/CE learning?

Please rate the professional practice value of each of the following in terms of improving your practice:

Today's CME event:
Direct to consumer advertising:
Sales representative visits:
Promotional/other non-certified education:
Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
What motivated you to participate in this activity? (check all that apply)